Effects of sacubitril/valsartan in ESRD patients undergoing hemodialysis with HFpEF

Effects of sacubitril/valsartan in ESRD patients undergoing hemodialysis with HFpEF

IntroductionHeart failure with preserved ejection fraction (HFpEF), which is a common co-morbidity in patients with maintenance hemodialysis (MHD), results in substantial mortality and morbidity. However, there are still no effective therapeutic drugs available for HFpEF currently. Sacubitril/valsar...

Full description

Bibliographic Details
Main Authors: Yanhong Guo, Mingjing Ren, Tingting Wang, Yulin Wang, Tian Pu, Xiaodan Li, Lu Yu, Liuwei Wang, Peipei Liu, Lin Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
heart failure with preserved ejection fraction
hemodialysis
sacubitril/valsartan
left ventricle dysfunction
pulmonary hypertension
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.955780/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.955780/full

Similar Items